Close

Clovis Oncology (CLVS) Posts Q2 Loss of 61c/Share, Narrower than Views

August 8, 2012 6:38 AM EDT
Clovis Oncology (NASDAQ: CLVS) reported Q2 EPS of ($0.61), $0.09 better than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings